BOSTON, MA, Embark Veterinary, a leader in dog genetics, announced $75 million in Series B funding. The round was led by Lydia Jett of SoftBank Vision Fund 2, with previous investors F-Prime Capital, SV Angel, Slow Ventures, Freestyle Capital, and Third Kind Venture Capital also participating.

Embark was launched in 2015 by two brothers, Adam and Ryan Boyko. Embark's Dog DNA Test tests for over 350 breeds, more than 200 genetic health risks, and many physical traits to empower dog owners, breeders, and veterinarians to make personalized care plans based on their dog's unique genetic profile.